Clinical Trials Logo

Clinical Trial Summary

The investigators plan to conduct this randomized sham-controlled clinical trial to evaluate the efficacy and safety of electroacupuncture (EA), compared with sham electroacupuncture (SA) on women with mixed urinary incontinence (MUI).


Clinical Trial Description

MUI tends to present with more severe symptoms and put greater burden on the health of individual and economy of society. Current European Association of Urology (EAU) guideline on incontinence recommends to initiate treatment targeted at predominant component of MUI. Electroacupuncture has been proved not inferior to pelvic floor muscle training plus solifenacin in decreasing the 72-hour IEF and shows promise as an effective alternative for the treatment of MUI. The purpose of the study is to assess the efficacy and safety of electroacupuncture on mixed urinary incontinence among women. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05505526
Study type Interventional
Source Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Contact Hangyu Shi
Phone +8618811735839
Email shihangyutcm@163.com
Status Not yet recruiting
Phase N/A
Start date August 18, 2022
Completion date December 31, 2024

See also
  Status Clinical Trial Phase
Not yet recruiting NCT00523068 - Pharmacological vs Surgical Treatment for Mixed Incontinence Phase 4
Recruiting NCT04299932 - Acupuncture for Stress-predominant Mixed Urinary Incontinence N/A
Completed NCT03632447 - Comparing Use of a Digital Health System of Pelvic Floor Exercise Program to Kegel Exercises in Stress Urinary Incontinence N/A
Recruiting NCT03803878 - Translation and Validation of MESA Questionnaire of Chinese Language Version
Recruiting NCT03787654 - Electroacupuncture and Solifenacin for Urgency-predominant Mixed Urinary Incontinence N/A
Terminated NCT03923348 - Pelvic Floor Muscle Training With Leva System for Urge Incontinence N/A
Completed NCT02678377 - The SLIM Study: Sling and Botox® Injection for Mixed Urinary Incontinence Phase 4
Completed NCT01493401 - Urinary Urinary Nerve Growth Factor (NGF) as a Biomarker for Mixed Urinary Incontinence N/A